Bruker Disagrees with ISS Recommendation on Board Vote | GenomeWeb

NEW YORK (GenomeWeb News) – Bruker said in a regulatory filing with the US Securities and Exchange Commission after the close of the market Tuesday that it disagrees with a recommendation from ISS Corporate Services that Bruker shareholders withhold votes from two of its directors, Richard Kniss and William Linton.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.